Celgene (NASDAQ:CELG) 4Q16 earnings sneak peak


Celgene (NASDAQ:CELG) biotech drug manufacturer is expected to report fourth quarter earnings results, before market open, on Thursday 26th January 2017.
Analysts polled by Thompson Reuters anticipate fourth quarter income of $ 1.59 per share from revenue of $ 3.02 billion.

Looking ahead, the full year income are expected at $ 5.92 per share on the revenues of $ 11.27 billion.

Comments are closed.